However , a significant difference in viral load was noted for the Vacc-4x group both at week 48 ( median 23,100 copies per mL Vacc-4x vs 71,800 copies per mL placebo ; p = 0025 ) and week 52 ( median 19,550 copies per mL vs 51,000 copies per mL ; p = 0041 ) .